MedPath

The Effect of Drug on the Patency Rate of Fistulae

Phase 3
Conditions
choronic renal failure.
End-stage renal disease
Registration Number
IRCT201009292220N3
Lead Sponsor
Vice-Chancellor for Research, Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
501
Inclusion Criteria

All end stage renal disease (ESRD) patients who needed Arterio-venous Fistulae (AVF) for hemodilysis. Exclusion criteria: bleeding tendency, active peptic ulcer disease, pregnancy, lactation, use of anticoagulant and or non steroidal anti-inflammatory drugs, hepatic insufficiency and history of significant side effects from aspirin or dipyridamol.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patency of Arterio-venous fistulae according age ,sex ,site. Timepoint: weekly. Method of measurement: presense or absence Thrill or bruit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath